In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...

Patients with metastatic non-small cell lung cancer, even those with brain metastases, experienced improved longer-term ...

In a new study of patients with metastatic non-small cell lung cancer, researchers found that patients who were more physically fit had better outcomes. With lung cancer claiming around 1.8 million ...

After feedback from the FDA, the companies have voluntarily withdrawn the previous biologics licensing application for ...

Canadian study reveals that women who undergo early menopause are less at risk for asthma than women who experience menopause ...

The future of the Affordable Care Act looks cloudier but the hot topic is the role that Robert F. Kennedy Jr. may play in the ...

Member experience, outcomes and medication adherence are the key areas of performance that Medicare Advantage plans should ...

Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

CT scans of the lungs can pick up early-stage lung cancers, but across the nation, less then 20% of those who are eligible ...

Qsymia’s manufacturer also released postmarketing data showing the oral therapy for weight loss was associated with reductions in 24-hour mean systolic blood pressure.

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...